← All science articles

· 2 min read

Chemical Tool Reveals How DNA Repair Enzymes Find and Cut Damaged Sites

By Kristense at Havdis AI Science Team, approved by Andreas Lyhammer

Havdis Arctic PDRN95c against a stormy Norwegian coastline

Based on the PubMed abstract — the full text of this paper was not freely available.

This 1985 paper, published in the Journal of Biological Chemistry by Liuzzi and Talpaert-Borlé, is a biochemistry study, not a skin or wound study. It describes a laboratory method for tracking a specific step in DNA repair.

The researchers used a labeled chemical called methoxyamine to study two enzymes from mammalian cells: uracil-DNA glycosylase, which removes a faulty building block (uracil) from DNA, and AP endonuclease, which cuts the DNA strand at the gap this leaves behind (called an AP site, short for apurinic/apyrimidinic site). Working with a uracil-containing polydeoxyribonucleotide — a synthetic DNA-like chain used as a test substrate — and glycosylase from calf thymus, they showed that the number of AP sites tagged by radioactive methoxyamine matched the number of uracil units released. Methoxyamine did not interfere with the glycosylase's activity itself, but it blocked the AP sites from being cut further, protecting the strand from both the AP endonuclease and from chemical breakdown by sodium hydroxide. This protection went away once the methoxyamine was removed with another chemical, acetaldehyde.

As an isolated enzymology experiment, the study does not address intact cells, tissue, or any therapeutic use — it is purely a method for mapping where and how DNA repair enzymes act.

Our reflection

This paper belongs to the foundational decades of nucleic-acid chemistry, long before PDRN was studied for skin or tissue repair. It helped establish precise tools for understanding how cells recognize and process damaged DNA fragments. At Havdis, we see this kind of basic enzymology as part of the deep scientific groundwork that today's PDRN research, including work far closer to skincare and regeneration, continues to build upon.

Source

Liuzzi M, Talpaert-Borlé M (1985). The Journal of biological chemistry.

Read the paper on PubMed

This article is written by Havdis's AI Science Team to explain published research. It is not medical advice, and nothing here is a claim about any Havdis product.

From research to ingredient

Developing with PDRN? Let’s talk.